Chemkart India (544442)
TurnaroundScore breakdown: P/E: 3/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹99.8 |
| Market Cap | ₹120.75 Cr |
| P/E Ratio | 6.34 |
| ROCE | 61.51% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | -35.1% |
| Debt/Equity | — |
| Sales Growth | -8.75% |
| Sector | Food Products |
Strengths
- High ROCE of 61.51% suggests strong capital efficiency if earnings are sustainable
- Low P/E of 6.34 against market cap of ₹121 Cr and quarterly profit of ₹10 Cr appears cheap
- Latest quarter net margin around 9.7% shows the business is still profitable
- Revenue base of ₹103 Cr per quarter provides some scale
Concerns
- Sales growth declined 8.75% and profit growth fell 35.10%, showing clear deterioration
- Piotroski F-Score of 3/9 indicates weak financial health and operational red flags
- Zero dividend yield means no current cash return for shareholders
- Critical data on book value, debt/equity, promoter holding, and ROE is unavailable, limiting analysis
AI Analysis
When I see a P/E of 6.34 and a ROCE of 61.51%, my interest is piqued. But Graham taught me that a cheap number can hide a deteriorating business. Chemkart operates in other food products and earned ₹10 crore net profit on ₹103 crore sales in the latest quarter — a roughly 9.7% margin. That is respectable. Yet the trend is troubling: sales have fallen 8.75% and profit has dropped 35.10%. The Piotroski F-Score of 3 out of 9 reinforces my caution; this is not a financially improving company. In fact, it seems to be getting weaker operationally. The market capitalisation is only ₹121 crore against a quarterly profit of ₹10 crore, so if this quarter is sustainable, the stock looks inexpensive. But that is a big if. With no dividend, no book value, no promoter holding data, and no debt-equity ratio reported, I cannot do full Graham-style balance sheet analysis. When key facts are missing, I either pass or demand a huge margin of safety. High ROCE may signal a decent capital-efficient business, but declining sales and profits, along with a weak F-score, tell me the moat is not protecting it right now. This could be a cyclical dip, a temporary setback, or a classic value trap. I would watch the next few quarters for stabilisation and need evidence of improving profitability and balance sheet strength. The low P/E offers opportunity only if the earning power holds; otherwise the market is simply repricing lower quality. In Buffett’s terms, it is far better to buy a wonderful business at a fair price than a struggling business at a low P/E. For now, this is a possible turnaround situation, not a business I would own without more transparency.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer